UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 90

Sortiert nach

Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas

Oncotarget, 2014-03, Vol.5 (6), p.1515-1525

2014

Link zum Volltext

Verfügbarkeit prüfen

The genetic landscape of anaplastic astrocytoma

Oncotarget, 2014-03, Vol.5 (6), p.1452-1457

2014

Link zum Volltext

Verfügbarkeit prüfen

AAL881, a novel small molecule inhibitor of RAF and vascular endothelial growth factor receptor activities, blocks the growth of malignant glioma

Cancer research (Chicago, Ill.), 2006-09, Vol.66 (17), p.8722-8730

2006

Link zum Volltext

Verfügbarkeit prüfen

ZD6474, a Novel Tyrosine Kinase Inhibitor of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor, Inhibits Tumor Growth of Multiple Nervous System Tumors

Clinical cancer research, 2005-11, Vol.11 (22), p.8145-8157

2005

Link zum Volltext

Verfügbarkeit prüfen

Central nervous system

Cancer biomarkers : section A of Disease markers, 2011-01, Vol.9 (1-6), p.193

2011

Link zum Volltext

Verfügbarkeit prüfen

Molecular pathogenesis of malignant gliomas

Current opinion in oncology, 1999-05, Vol.11 (3), p.162-162

1999

Link zum Volltext

Verfügbarkeit prüfen

PTEN gene mutations are seen in high-grade but not in low-grade gliomas

Cancer research (Chicago, Ill.), 1997-10, Vol.57 (19), p.4187-4190

1997

Link zum Volltext

Verfügbarkeit prüfen

Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft

Cancer research (Chicago, Ill.), 1997-07, Vol.57 (14), p.2933-2936

1997

Link zum Volltext

Verfügbarkeit prüfen

Production and Characterization of Two Ependymoma Xenografts

Journal of neuropathology and experimental neurology, 1996-05, Vol.55 (5), p.540-548

1996

Link zum Volltext

Verfügbarkeit prüfen

Glioblastoma Proto-oncogene SEC61γ Is Required for Tumor Cell Survival and Response to Endoplasmic Reticulum Stress

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (23), p.9105-9111

2009

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2435A: Identification and treatment data of xenografts representing TCGA-defined glioblastoma subtypes

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.2435-2435A

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4417: Characterization of xenograft-derived EGFRvIII-positive GBM cell cultures reveals functional interactions between EGFRvIII, wild-type EGFR, and p53

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.4417-4417

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract 838: Establishment, identification and treatment data of TCGA glioblatoma xenograft subtypes

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.838-838

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1846: Identification of a germline mutation in PMS2, a DNA mismatch repair gene, in a large consanguineous family with a history of Pediatric GBMs

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.1846-1846

2010

Link zum Volltext

Verfügbarkeit prüfen

EGFR mutations and sensitivity to gefitinib

The New England journal of medicine, 2004-09, Vol.351 (12), p.1260

2004

Link zum Volltext

Verfügbarkeit prüfen

EGFR Mutations and Sensitivity to Gefitinib

The New England journal of medicine, 2004-09, Vol.351 (12), p.1260-1261

Sorscher, Steven M

2004

Link zum Volltext

Verfügbarkeit prüfen

EGFR Mutations and Sensitivity to Gefitinib/THE AUTHORS REPLY

The New England journal of medicine, 2004-09, Vol.351 (12), p.1260

2004

Link zum Volltext

Verfügbarkeit prüfen

Alterations of the TP53 gene in human gliomas

Cancer research (Chicago, Ill.), 1994-03, Vol.54 (5), p.1324-1330

1994

Link zum Volltext

Verfügbarkeit prüfen

An Integrated Genomic Analysis of Human Glioblastoma Multiforme

Science (American Association for the Advancement of Science), 2008, Vol.321 (5897), p.1807-1812

2008

Link zum Volltext

Verfügbarkeit prüfen

Activation of potassium ion transport in mitochondria by cadmium ion

European journal of biochemistry, 1984-01, Vol.144 (3), p.643-647

1984

Link zum Volltext

Verfügbarkeit prüfen

Glioblastoma proto-oncogene SEC61gamma is required for tumor cell survival and response to endoplasmic reticulum stress

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (23), p.9105

2009

Link zum Volltext

Verfügbarkeit prüfen

Oncogenes and anti-oncogenes in human central nervous system tumors

Laboratory investigation, 1994-11, Vol.71 (5), p.621

1994

Link zum Volltext

Verfügbarkeit prüfen

Genetic alterations in glioma and medulloblastoma

Cancer and metastasis reviews, 1991-12, Vol.10 (4), p.289-299

1991

Link zum Volltext

Verfügbarkeit prüfen

Loss of heterozygosity for 10q loci in human gliomas

Genes chromosomes & cancer, 1992-07, Vol.5 (1), p.75-82

1992

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 90

Suche als RSS-Feed

Aktive Filter

ThemaTumors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(82)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas

The genetic landscape of anaplastic astrocytoma

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas

AAL881, a novel small molecule inhibitor of RAF and vascular endothelial growth factor receptor activities, blocks the growth of malignant glioma

ZD6474, a Novel Tyrosine Kinase Inhibitor of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor, Inhibits Tumor Growth of Multiple Nervous System Tumors

Central nervous system

Molecular pathogenesis of malignant gliomas

PTEN gene mutations are seen in high-grade but not in low-grade gliomas

Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft

Production and Characterization of Two Ependymoma Xenografts

Glioblastoma Proto-oncogene SEC61γ Is Required for Tumor Cell Survival and Response to Endoplasmic Reticulum Stress

Abstract 2435A: Identification and treatment data of xenografts representing TCGA-defined glioblastoma subtypes

Abstract 4417: Characterization of xenograft-derived EGFRvIII-positive GBM cell cultures reveals functional interactions between EGFRvIII, wild-type EGFR, and p53

Abstract 838: Establishment, identification and treatment data of TCGA glioblatoma xenograft subtypes

Abstract 1846: Identification of a germline mutation in PMS2, a DNA mismatch repair gene, in a large consanguineous family with a history of Pediatric GBMs

EGFR mutations and sensitivity to gefitinib

EGFR Mutations and Sensitivity to Gefitinib

EGFR Mutations and Sensitivity to Gefitinib/THE AUTHORS REPLY

Alterations of the TP53 gene in human gliomas

An Integrated Genomic Analysis of Human Glioblastoma Multiforme

Activation of potassium ion transport in mitochondria by cadmium ion

Glioblastoma proto-oncogene SEC61gamma is required for tumor cell survival and response to endoplasmic reticulum stress

Oncogenes and anti-oncogenes in human central nervous system tumors

Genetic alterations in glioma and medulloblastoma

Loss of heterozygosity for 10q loci in human gliomas

Aktive Filter

Suchergebnisse filtern